FDA Inspection 1217063 — Francisco L. Badar III, M.D.
The FDA completed an inspection of Francisco L. Badar III, M.D. on August 30, 2023 in Cerritos, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 30, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cerritos, CA (United States)
Additional Details
Clinical BA/BE